SCHEMBL6479954

SCHEMBL6479954

O=C(Cc1ccccc1)Nc1ccc2cc(-c3cn[nH]c3)[nH]c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 10/20 0.51
NAMPT P43490 1/20 0.49
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CLK2 P49760 2/20 0.45
CLK3 P49761 1/20 0.45
DYRK1A Q13627 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HDAC1 Q13547 1/20 0.45
ROCK1 Q13464 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
AURKA O14965 1/20 0.44
PRKX P51817 1/20 0.43
CAMK2D Q13557 1/20 0.43
PKN2 Q16513 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5814937 0.93 ROCK2 (0.52) ROCK2NAMPTKDM4ENPC1RAB9A
SCHEMBL5755889 0.84 PDE10A (0.50) ROCK2KDM4EROCK1ALDH1A1AURKA
SCHEMBL6478358 0.84 NTRK1 (0.57) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL6480489 0.83 ITK (0.46) ROCK2KDM4EALDH1A1AURKAFYN
SCHEMBL17407608 0.79 ROCK2 (0.77) ROCK2MEN1KMT2AROCK1
SCHEMBL5789255 0.79 PARP14 (0.50) ROCK2KDM4ECLK2CLK3DYRK1A
SCHEMBL5754607 0.78 NAMPT (0.71) ROCK2NAMPTROCK1
SCHEMBL5757280 0.78 AURKA (0.47) ROCK2ROCK1AURKAFYN
SCHEMBL6481076 0.77 PDE10A (0.51) ROCK2NAMPTKDM4ENPC1CLK2
SCHEMBL5760150 0.77 ROCK2 (0.64) ROCK2NAMPTNPC1RAB9AROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 ROCK2 600/4885NAMPT 1257/4885KDM4E 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.